Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
13.82
+0.75 (5.74%)
At close: Jan 16, 2026, 4:00 PM EST
13.85
+0.03 (0.22%)
After-hours: Jan 16, 2026, 6:57 PM EST
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $117.74 million as of January 16, 2026. Its market cap has decreased by -22.40% in one year.
Market Cap
117.74M
Enterprise Value
-32.20M
1-Year Change
-22.40%
Ranking
Category
Stock Price
$13.82
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $346.92M to $117.74M, a decrease of -66.06%. That is a compound annual growth rate of -13.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 117.74M | 19.45% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |